Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
基本信息
- 批准号:6934497
- 负责人:
- 金额:$ 119.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-15 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:agingantioxidantsbrainclinical researchcognitiondementiadisease /disorder prevention /controldisease /disorder proneness /riskepidemiologyfunctional abilitygene environment interactionhuman mortalityhuman subjecthuman very old age (85+)inflammationlongevitylongitudinal human studymental health epidemiologyneuropathologynonsteroidal antiinflammatory agentoxidative stresspostmortempsychological aspect of agingquestionnaires
项目摘要
DESCRIPTION (provided by applicant): In the next two decades, the number of Americans aged 90 years and older will nearly double to over 3 million people. Because previous studies have few, if any, subjects over 90 years of age, little is known about these pioneers or about factors associated with successful aging and health in this group.
The goals of this application are to investigate clinical, genetic, and pathological factors associated with extreme old age. We superimpose our investigations on the Leisure World Cohort Study, initiated in 1981. For over 20 years, cohort members (N=13,979) have provided medical history and lifestyle information including morbid conditions, family history, exercise, social activities, and medication use such as antioxidants and non-steroidal anti-inflammatory drugs(NSAIDS).
Our central hypothesis is that oxidative damage and inflammation in the brain results in aging, disease and death and that intake of antioxidants and NSAIDS will slow cognitive decline and improve the health of the oldest old.
Our Specific Aims are: (1) to examine factors associated with longevity in the 4,682 cohort members who reached age 90 compared to the 6734 who did not, (2) to determine the prevalence, incidence, and risk factors for dementia in 1,644 living cohort members in their tenth and eleventh decades, (3) to conduct longitudinal follow-up to measure rates of cognitive and functional decline in these oldest old subjects, and (4) to complete our investigations with clinical pathological correlates of brain aging in health and disease, focusing on the association of cerebral measures of oxidative injury, inflammatory markers, and plaque and tangle pathology as it relates to clinical status and previous use of antioxidant and anti-inflammatory compounds.
The Leisure World Cohort Study provides a unique population sample for the study of genetic and environmental factors associated with longevity and successful aging in the oldest old. With a substantial cohort of committed subjects and 20 years of prospective data, our proposed investigations can contribute much to the understanding of cognition, functional abilities, and cerebral pathology in the oldest members of our society.
描述(由申请人提供):在接下来的二十年里,美国90岁及以上的人数将增加近一倍,达到300多万人。因为之前的研究只有很少(如果有的话)90岁以上的受试者,所以对这些先驱者或与这一群体成功衰老和健康相关的因素知之甚少。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLAUDIA H. KAWAS其他文献
CLAUDIA H. KAWAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLAUDIA H. KAWAS', 18)}}的其他基金
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
白细胞衍生的生物标志物作为阿尔茨海默病风险和进展的预测因子
- 批准号:
8166929 - 财政年份:2009
- 资助金额:
$ 119.18万 - 项目类别:
LEUKOCYTE-DERIVED BIOMARKERS AS PREDICTORS OF RISK AND PROGRESSION IN ALZHEIMER'
白细胞衍生的生物标志物作为阿尔茨海默病风险和进展的预测因子
- 批准号:
7951079 - 财政年份:2008
- 资助金额:
$ 119.18万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
8230622 - 财政年份:2002
- 资助金额:
$ 119.18万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
7463369 - 财政年份:2002
- 资助金额:
$ 119.18万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
6907727 - 财政年份:2002
- 资助金额:
$ 119.18万 - 项目类别:
Clinical and Pathological Studies in the Oldest Old
最古老的临床和病理学研究
- 批准号:
7496763 - 财政年份:2002
- 资助金额:
$ 119.18万 - 项目类别:
相似海外基金
Sex-dependent synergy between O3 exposure, APOE4 e4 genotype, and aging in the onset of Alzheimer's disease
O3 暴露、APOE4 e4 基因型和衰老在阿尔茨海默病发病过程中的性别依赖性协同作用
- 批准号:
10584765 - 财政年份:2023
- 资助金额:
$ 119.18万 - 项目类别:
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
Mito-Frail 试验:MitoQ 对体弱老年人的血管舒张、活动能力和认知能力的影响
- 批准号:
10572663 - 财政年份:2023
- 资助金额:
$ 119.18万 - 项目类别:
Aging, PTSD, and the Anterior Cingulate Cortex (ACC)
衰老、创伤后应激障碍 (PTSD) 和前扣带皮层 (ACC)
- 批准号:
10587057 - 财政年份:2023
- 资助金额:
$ 119.18万 - 项目类别:
Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD study
肾素血管紧张素系统对阿尔茨海默病过程中 MRI 体积测量和认知功能的影响:LookAHEAD 研究
- 批准号:
10447980 - 财政年份:2022
- 资助金额:
$ 119.18万 - 项目类别:
The Impact of Weight Loss on Alzheimer's Disease Risk in Adults with Down Syndrome
减肥对唐氏综合症成人阿尔茨海默病风险的影响
- 批准号:
10518635 - 财政年份:2022
- 资助金额:
$ 119.18万 - 项目类别:
Neuroprotective actions of cystathionine g-lyase through gasotransmitter hydrogen sulfide signaling
胱硫醚 G-裂解酶通过气体递质硫化氢信号传导的神经保护作用
- 批准号:
10445502 - 财政年份:2022
- 资助金额:
$ 119.18万 - 项目类别:
Understanding metabolic changes associated with chronic manganese exposure and Alzheimer's Disease
了解与慢性锰暴露和阿尔茨海默病相关的代谢变化
- 批准号:
10353617 - 财政年份:2022
- 资助金额:
$ 119.18万 - 项目类别:
Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD study
肾素血管紧张素系统对阿尔茨海默病过程中 MRI 体积测量和认知功能的影响:LookAHEAD 研究
- 批准号:
10645040 - 财政年份:2022
- 资助金额:
$ 119.18万 - 项目类别:














{{item.name}}会员




